NO20074504L - Farmasoytisk aktive forbindelser, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse - Google Patents

Farmasoytisk aktive forbindelser, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse

Info

Publication number
NO20074504L
NO20074504L NO20074504A NO20074504A NO20074504L NO 20074504 L NO20074504 L NO 20074504L NO 20074504 A NO20074504 A NO 20074504A NO 20074504 A NO20074504 A NO 20074504A NO 20074504 L NO20074504 L NO 20074504L
Authority
NO
Norway
Prior art keywords
preparation
active compounds
compositions containing
pharmaceutically active
substance
Prior art date
Application number
NO20074504A
Other languages
English (en)
Other versions
NO341846B1 (no
Inventor
Maurice Sydney Newton
Nigel Peter Rhodes
Alexis John Toft
Original Assignee
Ineos Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ineos Healthcare Ltd filed Critical Ineos Healthcare Ltd
Publication of NO20074504L publication Critical patent/NO20074504L/no
Publication of NO341846B1 publication Critical patent/NO341846B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Iron (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

En substans for anvendelse som et medikament som omfatter en fast blandet metallforbindelse med formel (I): MII1-aMIIIaObAn-c.zH2O (I) hvor MII er i det minste ett bivalent metall; MIII er i det minste ett trivalent metall; An- er i det minste ett n-valent anion; 2+a = 2b+Scn; og Scn < 0,9 a. Substansen kan fremstilles ved oppvarming ved en temperatur fra 200°C til 600°C, foretrukket fra 250°C til 500°C av en substans omfattende en forbindelse med formel (II): MII1-xMIIIx(OH)2An-y. mH20 (II) hvor MII er i det minste ett bivalent metall; MIII er i det minste ett trivalent metall; An- er i det minste ett n-valent anion; x = Syn 0 < x < 0,5, 0 < y < 1 og 0 < m < 10.
NO20074504A 2005-02-10 2007-09-05 Substans for anvendelse som et medikament, fremgangsmåte for fremstilling derav, farmasøytisk formulering og fremgangsmåte for fremstilling derav. NO341846B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0502787.5A GB0502787D0 (en) 2005-02-10 2005-02-10 Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
PCT/GB2006/000452 WO2006085079A2 (en) 2005-02-10 2006-02-09 Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use

Publications (2)

Publication Number Publication Date
NO20074504L true NO20074504L (no) 2007-11-12
NO341846B1 NO341846B1 (no) 2018-02-05

Family

ID=34356109

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20074504A NO341846B1 (no) 2005-02-10 2007-09-05 Substans for anvendelse som et medikament, fremgangsmåte for fremstilling derav, farmasøytisk formulering og fremgangsmåte for fremstilling derav.
NO20171769A NO20171769A1 (no) 2005-02-10 2017-11-08 Fremgangsmåte for fremstilling av en substans for anvendelse som et medikament

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20171769A NO20171769A1 (no) 2005-02-10 2017-11-08 Fremgangsmåte for fremstilling av en substans for anvendelse som et medikament

Country Status (20)

Country Link
US (2) US20080206358A1 (no)
EP (2) EP3120855A1 (no)
JP (2) JP5328157B2 (no)
KR (3) KR20140066756A (no)
CN (2) CN101115490B (no)
AR (2) AR053678A1 (no)
AU (1) AU2006213922B2 (no)
BR (1) BRPI0606923B1 (no)
CA (1) CA2597124C (no)
ES (1) ES2599152T3 (no)
GB (1) GB0502787D0 (no)
IL (1) IL184448A (no)
MX (1) MX2007009688A (no)
MY (1) MY150070A (no)
NO (2) NO341846B1 (no)
NZ (1) NZ556600A (no)
RU (1) RU2420297C2 (no)
TW (1) TWI461201B (no)
WO (1) WO2006085079A2 (no)
ZA (1) ZA200706160B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) * 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
GB201005931D0 (en) 2010-04-09 2010-05-26 Isis Innovation Immune modulation
US9649335B1 (en) * 2016-03-30 2017-05-16 Baylor University Intravenous administration of an oxygen-enabled fluid
CA3116635A1 (en) 2018-10-25 2020-04-30 Opko Ireland Global Holdings, Ltd Methods of treatment with mixed metal compounds
RU2758671C1 (ru) * 2020-12-08 2021-11-01 Федеральное государственное бюджетное учреждение науки Институт физики прочности и материаловедения Сибирского отделения Российской академии наук (ИФПМ СО РАН) СПОСОБ ПОЛУЧЕНИЯ НАНОСТРУКТУРНЫХ ДВОЙНЫХ ГИДРОКСИДОВ НА ОСНОВЕ АЛЮМИНИЯ И ЩЕЛОЧНОЗЕМЕЛЬНЫХ МЕТАЛЛОВ, ТАКИХ КАК МАГНИЙ ИЛИ КАЛЬЦИЙ, ОБЛАДАЮЩИХ СВОЙСТВОМ ПОВЫШАТЬ pH КЛЕТОЧНОЙ СРЕДЫ, И НАНОСТРУКТУРЫ, ПОЛУЧЕННЫЕ ДАННЫМ СПОСОБОМ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2838930C2 (de) * 1978-09-07 1980-07-03 Chemische Werke Huels Ag, 4370 Marl Wäßriges Behandlungsmittel für Holz und Holzwerkstoffe und dessen Verwendung
US4514389A (en) * 1981-05-06 1985-04-30 Kyowa Chemical Industry Co. Ltd. Gastric antacid and method for controlling pH of gastric juice
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US4566986A (en) * 1984-08-31 1986-01-28 Waldmann John J Flocculating agents and processes for making them
US5153156A (en) * 1989-04-18 1992-10-06 Aristech Chemical Corporation Process for making efficient anionic clay catalyst, catalysts made thereby, and method of making isophorone
US5246899A (en) * 1991-08-16 1993-09-21 Amoco Corporation Simplified preparation of hydrotalcite-type clays
NL9201907A (nl) * 1992-11-02 1994-06-01 Tno Peristaltisch mengende reactor en peristaltische kleppenpomp.
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
GB9506126D0 (en) * 1995-03-25 1995-05-10 Johnson Matthey Plc Pharmaceutical composition and method
GB9720061D0 (en) * 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6720005B1 (en) * 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
AU2002346065A1 (en) * 2001-07-05 2003-01-21 Marantech Holding, Llc Methods of using electron active compounds for managing conditions afflicting mammals
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
JP4348426B2 (ja) * 2002-08-29 2009-10-21 独立行政法人産業技術総合研究所 高選択性脱リン剤及びその製造方法
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
EP1696889A1 (en) * 2003-08-28 2006-09-06 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of benzimidazole and processes for their preparation
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate

Also Published As

Publication number Publication date
IL184448A0 (en) 2007-10-31
MY150070A (en) 2013-11-29
NO341846B1 (no) 2018-02-05
CA2597124A1 (en) 2006-08-17
AU2006213922B2 (en) 2011-09-29
EP1850859B1 (en) 2016-07-20
IL184448A (en) 2014-12-31
JP5328157B2 (ja) 2013-10-30
KR20130121186A (ko) 2013-11-05
CN105412150A (zh) 2016-03-23
AU2006213922A1 (en) 2006-08-17
TWI461201B (zh) 2014-11-21
EP1850859A2 (en) 2007-11-07
CN101115490B (zh) 2015-12-09
KR20140066756A (ko) 2014-06-02
AU2006213922A2 (en) 2006-08-17
US20120093943A1 (en) 2012-04-19
NO20171769A1 (no) 2007-11-12
RU2007133720A (ru) 2009-03-20
ZA200706160B (en) 2009-02-25
JP2013209401A (ja) 2013-10-10
BRPI0606923A2 (pt) 2009-12-01
AR106699A2 (es) 2018-02-07
KR101491531B1 (ko) 2015-03-09
GB0502787D0 (en) 2005-03-16
KR20070082918A (ko) 2007-08-22
WO2006085079A3 (en) 2006-12-14
RU2420297C2 (ru) 2011-06-10
TW200640476A (en) 2006-12-01
CN101115490A (zh) 2008-01-30
ES2599152T3 (es) 2017-01-31
NZ556600A (en) 2010-02-26
JP2008530065A (ja) 2008-08-07
EP3120855A1 (en) 2017-01-25
BRPI0606923B1 (pt) 2019-06-18
WO2006085079A2 (en) 2006-08-17
MX2007009688A (es) 2008-01-22
CA2597124C (en) 2015-11-24
CN105412150B (zh) 2019-05-17
US20080206358A1 (en) 2008-08-28
AR053678A1 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
NO20074504L (no) Farmasoytisk aktive forbindelser, deres fremstilling, sammensetninger inneholdende dem og deres anvendelse
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NO20064588L (no) Delta d-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende den
NO20060949L (no) yd-krystallinsk form avivabradin-hydroklorid, fremgangsmate for dens frem5l1lling 0g farmasoytiske sammensetninger inneholdende den
MD4302C1 (ro) Compoziţii erbicide ce conţin un derivat al benzoilpirazolului
NO20063931L (no) Nye sammensetninger inneholdende kinolinforbindelser
UA83718C2 (ru) Кристаллическая форма iv агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит
IL198115A (en) The heteroaryl compounds, their vehicles, and their use in drug preparation
PE20051094A1 (es) Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico y procesos para su preparacion
UA97351C2 (ru) Производная кумарина, имеющая противоопухолевую активность
UA99908C2 (ru) Пиридопиразиновые производные, способ борьбы с растениями, гербицидные композиции
NO20060947L (no) β d-krystalinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
NZ587051A (en) Isoquinolinone derivatives, compositions and methods of inhibiting phosphatidyl inositol-3 kinase (pi3 kinase)
NO20060946L (no) β-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
WO2008093840A1 (ja) ベンゾイルピラゾール系化合物を含有する除草性組成物
UA91395C2 (ru) 1-(азолин-2-ил)-амино-1-фенил-2-гетарилетановое соединение, инсектицидная композиция на ее основе и способы борьбы с насекомыми (варианты)
NO20060948L (no) Á-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
WO2008021927A3 (en) Hepatitis c virus inhibitors
UA97478C2 (ru) Кристаллическая форма vi агомелатина, способ ее приготовления (варианты) и фармацевтическая композиция, которая ее содержит
WO2008036308A3 (en) Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
UA89123C2 (ru) Производные пиримидина для лечения абнормального роста клеток
NO20052998L (no) Alfa krystallinsk form av strontiumranelat, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den.
NO20080779L (no) Nye farmasoytiske forbindelser
EA200801777A1 (ru) α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, КОТОРЫЕ ЕЁ СОДЕРЖАТ

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees